Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk
Antibody–drug conjugates transform the outcome of individuals with low-HER2-expression advanced breast cancer 10.1002/cncr.35205
Association of travel time, patient characteristics, and hospital quality with patient mobility for breast cancer surgery: A national population-based study 10.1002/cncr.35153
Endocrine therapy for cancer 10.1016/j.mpsur.2023.12.005
Fostering resilience in adolescence and young adulthood: Considerations for evidence-based, patient-centered oncology care 10.1002/cncr.35182 See also: Resilience in adolescent and young adult oncology: problems and prospects 10.1002/cncr.35180
Hereditary and familial cancer 10.1016/j.mpsur.2023.12.008
The impact of COVID-19 on patients diagnosed with melanoma, breast, and colorectal cancer 10.1016/j.amjsurg.2023.09.040
Lung cancer statistics, 2023 10.1002/cncr.35128
Maintenance and consolidation strategies for patients with untreated advanced follicular lymphoma: A systematic review and network meta-analysis of randomized trials 10.1002/cncr.35137
Managing menopause after cancer 10.1016/S0140-6736(23)02802-7
Microwave coagulation for liver metastases (updated Cochrane intervention review) 10.1002/14651858.CD010163.pub3
Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer 10.1016/S1470-2045(23)00676-9
Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients 10.1002/cncr.35220
Primary care clinicians’ perspectives on interacting with patients with gynaecological conditions: a systematic review 10.3399/BJGPO.2023.0133
Principles of cancer screening 10.1016/j.mpsur.2023.12.003
Principles of cancer treatment by radiotherapy 10.1016/j.mpsur.2023.12.001
The principles of neoplasia and oncology 10.1016/j.mpsur.2023.12.002
Principles of systemic anticancer therapy (SACT) 10.1016/j.mpsur.2023.12.015
The role of the surgeon in cancer care 10.1016/j.mpsur.2023.12.006
The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions 10.1016/S1470-2045(23)00636-8
Targeted therapies in cancer 10.1016/j.mpsur.2023.12.004
American Journal of Surgery (Mar); BJGP Open (Mar); Cancer (Apr-1st May); Cochrane Library (Mar-Apr); Lancet, The (9th-15th Mar); Lancet Oncology, The (Apr); Surgery – Oxford (Mar)
Cancer care and treatment during homelessness 10.1016/S1470-2045(23)00567-3
Cancer diagnoses after recent weight loss 10.1001/jama.2023.25869
Co-design and evaluation of a digital serious game to promote public awareness about pancreatic cancer 10.1186/s12889-024-18050-7
Employment and workdays lost among spouses of cancer survivors: Intersection with gender across cancer treatment status 10.1002/cncr.35070
Fertility preservation before and after cancer treatment in children, adolescents, and young adults 10.1002/cncr.35108
Functional outcomes after localized prostate cancer treatment 10.1001/jama.2023.26491
The future of cancer care in the UK—time for a radical and sustainable National Cancer Plan 10.1016/S1470-2045(23)00511-9
How much do Europeans know about the link between alcohol use and cancer? 10.1186/s13104-024-06707-w
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer 10.1016/S1470-2045(23)00534-X
Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England 10.1136/bmj-2023-075498
It takes more than rainbows: supporting sexual and gender minority patients with trauma-informed cancer care 10.1002/cncr.35120
Living alone and cancer mortality by race/ethnicity and socioeconomic status among US working-age adults 10.1002/cncr.35042
Multiscale spatial mapping of cell populations across anatomical sites in healthy human skin and basal cell carcinoma 10.1073/pnas.231332612
Non-surgical ablation for breast cancer: an emerging therapeutic option 10.1016/S1470-2045(23)00615-0
Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia 10.1002/cncr.35021
PET-based response assessment criteria for diffuse gliomas 10.1016/S1470-2045(23)00525-9
A potential biomarker of radiosensitivity in metastatic hormone sensitive prostate cancer patients treated with combination external beam radiotherapy and radium-223 10.1016/j.radonc.2023.110063
Prognosis and risk of suicide after cancer diagnosis 10.1002/cncr.35118
Risk of chronic health conditions in lesbian, gay, and bisexual survivors of adolescent and young adult cancers 10.1002/cncr.35015
Stage IV breast, colorectal, and lung cancer at diagnosis in adults living with intellectual or developmental disabilities 10.1002/cncr.35068
Stereotactic body radiotherapy for primary renal cell carcinoma 10.1016/S1470-2045(23)00513-2
BMC Public Health (Feb); BMC Research Notes (Feb); BMJ (24th Jan); Cancer (Jan-Mar); JAMA (23rd/30th Jan); Lancet Oncology, The (Jan-Mar); PNAS (Jan); Radiotherapy and Oncology (Dec)
Advancing immunotherapy in small cell lung cancer DOI: 10.1002/cncr.34977
Cannabinoids for symptom management in children with cancer: A systematic review and meta-analysis DOI: 10.1002/cncr.34920
Cannabis use among adults undergoing cancer treatment DOI: 10.1002/cncr.34922
Effects of trauma history on cancer-related screening, diagnosis, and treatment DOI: 10.1016/S1470-2045(23)00438-2
Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer (updated NICE guideline CG164)
Future cancer risk after urgent suspected cancer referral in England when cancer is not found: a national cohort study DOI: 10.1016/S1470-2045(23)00435-7
Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide DOI: 10.1016/S1470-2045(23)00412-6
New era for myelofibrosis treatment with novel agents beyond Janus kinase-inhibitor monotherapy: Focus on clinical development of BCL-XL/BCL-2 inhibition with navitoclax DOI: 10.1002/cncr.34986
Oncology hospitalist impact on hospice utilization DOI: 10.1002/cncr.35008
Ovarian cancer: recognition and initial management (updated NICE guideline CG122)
Parents’ and adolescents’ perspectives and understanding of information about childhood cancer precision medicine DOI: 10.1002/cncr.34914
Predictive factors of long-term follow-up attendance in very long-term childhood cancer survivors DOI: 10.1002/cncr.34944
Promoting lung cancer screening of high-risk patients by primary care providers DOI: 10.1002/cncr.34955
Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14,324 women in 16 trials DOI: 10.1016/S0140-6736(23)01082-6
Recent histone deacetylase inhibitors in cancer therapy DOI: 10.1002/cncr.34974
Relationship between survivorship care plans and unmet information needs, quality of life, satisfaction with care, and propensity to engage with, and attend, follow-up care DOI: 10.1002/cncr.34984
Suspected cancer: recognition and referral (updated NICE guideline NG12)
What are the most effective exercise, physical activity and dietary interventions to improve body composition in women diagnosed with or at high-risk of breast cancer? A systematic review and network meta-analysis DOI: 10.1002/cncr.35043
Sources used: Cancer (Nov, 1st Dec); Lancet, The (25th Nov-01 Dec); NICE (Oct, Nov); Lancet Oncology, The (Nov, Dec)